Search

A program aimed at raising awareness of the dangers of a chronic wet cough in Aboriginal children has been extended to 14 remote and regional towns in Western Australia - thanks to a partnership between The Kids Research Institute Australia and Cystic Fibrosis WA.

An exciting study is investigating whether a new therapeutic treatment for asthma will protect young sufferers from ongoing lung damage and improve their long-term health outcomes.

What if researchers could shop for different data to help uncover how, when and why chronic conditions such as asthma, obesity, allergies and poor mental health develop?

While COVID-19 is new and frightening, these resources are designed to help families tackle the challenges this virus has created for us.

Research

RSV hospitalises millions of babies worldwide every year: our research is helping to change that.

Research

Dietary intake during the first year of life is a key determinant of a child's growth and development. ORIGINS is a longitudinal birth cohort study investigating factors that contribute to a 'healthy start to life' and the prevention of non-communicable diseases.

Between 1989 and 1991, almost 3,000 WA babies were recruited to the Raine Study - an ambitious research project which would yield a series of paradigm-shifting findings that changed scientific thinking. Three decades on, it has also changed the lives of those taking part.

The Yawardani Jan-ga Equine-Assisted Learning (EAL) research project, headed by Professor Juli Coffin in WA’s Kimberley region, is steadily growing its capacity to support the social, emotional and spiritual wellbeing of Aboriginal young people through the powerful medium of horses.

Research

Respiratory infection and wheezing illness are leading causes of hospitalisation in childhood, placing a significant burden on families and healthcare systems. However, reliably distinguishing children at risk of developing persistent disease from those likely to outgrow their symptoms remains a clinical challenge. Earlier identification would allow clinicians to focus care and resources on those most likely to benefit from long-term management, while reducing anxiety and uncertainty about the future for families.

Research

Despite advances in immunotherapy, metastatic melanoma remains a considerable therapeutic challenge due to the complexity of the tumor microenvironment. Intratumoral type I interferon (IFN-I) has long been associated with improved clinical outcomes. However, several IFN-I subtypes can also paradoxically promote tumor growth in some contexts.